<SEC-DOCUMENT>0001144204-18-066573-index.html : 20181228
<SEC-HEADER>0001144204-18-066573.hdr.sgml : 20181228
<ACCEPTANCE-DATETIME>20181228161251
ACCESSION NUMBER:		0001144204-18-066573
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20181221
FILED AS OF DATE:		20181228
DATE AS OF CHANGE:		20181228

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Moseley Ken
		CENTRAL INDEX KEY:			0001626895

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37939
		FILM NUMBER:		181257558

	MAIL ADDRESS:	
		STREET 1:		C/O BELLICUM PHARMACEUTICALS, INC.
		STREET 2:		2130 W. HOLCOMBE BLVD., STE. 800
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77030

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Marker Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001094038
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880277072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		5 WEST FORSYTH STREET
		STREET 2:		SUITE 200
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32202
		BUSINESS PHONE:		(904) 516-5436

	MAIL ADDRESS:	
		STREET 1:		5 WEST FORSYTH STREET
		STREET 2:		SUITE 200
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TAPIMMUNE INC.
		DATE OF NAME CHANGE:	20170629

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TAPIMMUNE INC
		DATE OF NAME CHANGE:	20070628

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENEMAX CORP
		DATE OF NAME CHANGE:	20020718
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tv510024_form3.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tv510024_form3.html

Document 1 - RAW XML: tv510024_form3.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>tv510024_ex24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
Document 2 - file: tv510024_ex24.htm

</DOCUMENT>
</SEC-DOCUMENT>